Atlas Trials

A Study to Investigate the Efficacy and Safety of OTL-203 in Subjects With MPS-IH Compared With Standard of Care With Allogeneic HSCT

Clinical trial NCT06149403 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06149403
Sponsor
Orchard Therapeutics
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
MPS-IH (Hurler Syndrome)
Start date
2023-12-11
Primary completion
2028-03-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.